Robert J. Flanagan, 69 Independent Director Since 2018 W. P. Carey Committees Audit (Chair), Investment Professional Experience CNF Investments LLC: Managing Director (since 2006) Clark Enterprises, Inc.: Executive Chairman (January 2023 December 2025), Chief Executive Officer (January 2021 December 2022), President (2015 2020), Executive Vice President (1989 2015) A. James & Alice B. Clark Foundation: Trustee (2014 December 2025), Chairman (2015 2016), Director (2009 2016) Non-Public Company Boards: Brown Advisory Inc. (since 2016) Former Boards: Vascular Therapies, Inc. (2013 March 2025); Svelte Medical Systems, Director (2005 October 2023); Verax Biomedical, Director (2018 January 2023; Clark Enterprises Inc., Director (2008 January 2023); Development Insurance Group, Inc., Director (2008 January 2023); Federal City Council, Chairman (2014 2017); Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT), Chairman (2015 2016), Director (2009 2016); Martek Biosciences Corporation (NASDAQ: MATK), Chairman (2007 2010), Director (2002 2010); Baltimore Orioles, Inc., Director and Treasurer (1981 1989) Other Current Public Company Boards None Qualifications Mr. Flanagan has extensive experience related to the acquisition, management and development of investment opportunities. His breadth of professional experiences is informed by expertise in a variety of subject areas, including accounting, finance, tax, strategic planning, leadership of complex organizations, corporate governance and board best practices. Mr. Flanagan's experience as a chief executive officer, certified public accountant, president and public company board member qualify him to be Chair of the Audit Committee. Strategic Planning Accounting & Financial International Business Risk Management & Oversight U.S. Public Company Executive Officer Public & Private Capital Markets Real Estate